News Archives - Page 68 of 87

WednesdayNov 09, 2022 10:30 am

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Reports Financial Numbers, Business Updates for Q3 2022

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is reporting its third-quarter 2022 results. Highlights of the financial report include a 171% increase in product revenue, which totaled $1.8 million, and minimal development revenue coming in at $1.2 million. The company also reported third quarter 2022 GAAP net loss totaled $17.4 million compared to GAAP net loss of $7.9 million in the prior year period with Q3 2022 non-GAAP net loss reaching $13.2 million compared to non-GAAP net loss of $6.6 million in 2021. The report noted that full year 2022 revenue is still expected to…

TuesdayNov 08, 2022 1:10 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Inks New 22-Device Contract with Florida College

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has signed an agreement to deploy 22 K1 Blue Light Towers at a Florida college. According to the announcement, many schools are ill-equipped to address campus safety challenges because of staffing shortages and budget constraints. Knightscope’s proprietary tech and devices provide key solutions to their challenges. The new college contract includes the retrofitting of 13 emergency call systems and the replacement of older, hardwired towers at two separate locations. The Florida college will be leveraging Knightscope’s cellular and satellite communications with solar power to offer students, faculty and visitors…

TuesdayNov 08, 2022 12:55 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences 1st-Ever Study Evaluating DehydraTECH-CBD’s Effect on Diabetes

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that study program DIAB-A22-1 is expected to begin on schedule today. According to the announcement, this is Lexaria’s first-ever study to investigate whether its patented DehydraTECH-processed cannabidiol (“CBD”) may potentially have therapeutic utility against diabetes. The company has evidenced the safety and efficacy of DehydraTECH-CBD in human hypertension studies. Strong connections exist between heart disease, hypertension and diabetes, with hypertension twice as frequent in diabetics and hypertensive patients at greater risk of developing diabetes. Diabetes, which prevents the body from making enough insulin and results in…

MondayNov 07, 2022 12:09 pm

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2022 Results, Continued Strengthening of Leading Position in Uranium, Rare Earth Elements

Energy Fuels (NYSE American: UUUU) (TSX: EFR) announced its financial results for the quarter ended Sept. 30, 2022. Among the highlights, the company reported a robust balance sheet with $122.3 million of working capital as of Sept. 30, 2022, including $77.1 million of cash and cash equivalents, $11.6 million of marketable securities, $27.3 million of inventory, and no short-term (or long-term) debt. The company’s product inventory has a value of $44.1 million at current commodity prices. “Energy Fuels continues to strengthen our U.S. market leading position in uranium and rare earth elements, which are both critical to the clean energy…

MondayNov 07, 2022 11:42 am

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Partner with Leading Entities to Complete Project Resulting in Enhanced Road Safety

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, has joined with two other leading companies to complete a proof-of-concept project confirming that an integrated system has the ability to warn drivers of unseen hazards ahead. The other two companies involved in the project, dubbed Periscope, are ALP.Lab GmbH, an Austria-based technology provider of autonomous vehicle testing solutions, and TE Connectivity, a world leader in sensors and connectors. According to the announcement, Periscope relies on lidar sensors strategically located at intersections to extend a driver’s field of view and alert them about a pedestrian approximately five seconds…

MondayNov 07, 2022 11:12 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Featured in Cleantech and Climate Change Podcast

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in a new edition of the Cleantech and Climate Change Podcast issued by Investorideas.com, a global news source and leading investor resource covering clean technology and renewable energy stocks issues. Mullen’s Founder, Chairman and CEO David Michery joined the podcast to discuss recent news and milestones and lay out Mullen’s future plans for manufacturing and sales. During the interview, Michery goes into detail on the significance of Mullen’s acquisition and controlling interest in EV truck innovator, Bollinger Motors (the company’s first EV acquisition), and the purchase of ELMS…

FridayNov 04, 2022 1:00 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Full Acquisition of Interest in RKings Competitions

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, has acquired the remaining 20% interest in RKings Competitions; the company now owns a total of 165,444 restricted shares of GMGI’s common stock payable to the two former owners of RKings. Company officials announced the transaction, which makes RKings a wholly owned entity of Golden Matrix, one which the company anticipates will grow quickly in several regulated jurisdictions, including Great Britain and Mexico. The company plans to expand the tournament platform into other Latin American markets in the next few years. In addition, Golden Matrix…

ThursdayNov 03, 2022 12:22 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 13th Craig-Hallum Alpha Select Conference

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 13th Craig-Hallum Alpha Select Conference. The event is slated to be held in New York City on Nov. 17, 2022. Cepton management will be available for group investor or one-on-one meetings throughout the conference. Interested parties should contact InvestorRelations@Cepton.com or their Craig-Hallum representative for related inquiries. To view the full press release, visit https://ibn.fm/kcm7E About Cepton Inc. Cepton is a Silicon Valley innovator of lidar-based solutions…

ThursdayNov 03, 2022 11:13 am

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation Schedule for Upcoming Investor Events

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced its participation in upcoming investor events. The company’s Chief Executive Officer Doug Drysdale will present and host investor meetings at the Jefferies London Healthcare Conference taking place on Nov. 15-17, 2022. Drysdale’s presentation is slated to begin at 8:00 a.m. GMT on Nov. 15. Drysdale will also participate in a panel discussion titled “Psychedelics Landscape – What can we expect?” at 5:00 p.m. GMT on Nov. 16, 2022, at the Pinsent Masons Psychedelics Panel in London, U.K. In addition, Drysdale will participate in…

WednesdayNov 02, 2022 11:52 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Doses First Patient in Global Berubicin Trial Evaluating GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has provided an update on enrollment of its ongoing trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. The company announced that the first patient in Europe has been enrolled in the study and has started receiving dosages. Eventually the company plans to have 68 sites opened for the ongoing…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News